Related Experiment Video
Updated: Apr 29, 2026

Analyzing the Functions of Mast Cells In Vivo Using 'Mast Cell Knock-in' Mice
Published on: May 27, 2015
Importance of mast cell Prss31/transmembrane tryptase/tryptase-γ in lung function and experimental chronic
Philip M Hansbro1, Matthew J Hamilton2, Michael Fricker1
1From the Centre for Asthma and Respiratory Disease, University of Newcastle and Hunter Medical Research Institute, Newcastle, New South Wales 2308, Australia.
Abstract:
Protease serine member S31 (Prss31)/transmembrane tryptase/tryptase-γ is a mast cell (MC)-restricted protease of unknown function that is retained on the outer leaflet of the plasma membrane when MCs are activated. We determined the nucleotide sequences of the Prss31 gene in different mouse strains and then used a Cre/loxP homologous recombination approach to create a novel Prss31(-/-) C57BL/6 mouse line. The resulting animals exhibited no obvious developmental abnormality, contained normal numbers of granulated MCs in their tissues, and did not compensate for their loss of the membrane tryptase by increasing their expression of other granule proteases. When Prss31-null MCs were activated with a calcium ionophore or by their high affinity IgE receptors, they degranulated in a pattern similar to that of WT MCs. Prss31-null mice had increased baseline airway reactivity to methacholine but markedly reduced experimental chronic obstructive pulmonary disease and colitis, thereby indicating both beneficial and adverse functional roles for the tryptase. In a cigarette smoke-induced model of chronic obstructive pulmonary disease, WT mice had more pulmonary macrophages, higher histopathology scores, and more fibrosis in their small airways than similarly treated Prss31-null mice. In a dextran sodium sulfate-induced acute colitis model, WT mice lost more weight, had higher histopathology scores, and contained more Cxcl-2 and IL-6 mRNA in their colons than similarly treated Prss31-null mice. The accumulated data raise the possibility that inhibitors of this membrane tryptase may provide additional therapeutic benefit in the treatment of humans with these MC-dependent inflammatory diseases.
Insights
Protease serine member S31 (Prss31) is a mast cell protease with dual roles. Deleting Prss31 reduced inflammation in lung and gut diseases but increased airway reactivity.
Area of Science:
- Immunology
- Molecular Biology
- Pulmonary Medicine
Background:
- Protease serine member S31 (Prss31), also known as transmembrane tryptase or tryptase-γ, is a mast cell-restricted protease.
- Its function and role in mast cell activation and inflammatory diseases remain largely unknown.
Purpose of the Study:
- To investigate the in vivo function of Prss31 by generating and characterizing Prss31-null mice.
- To determine the role of Prss31 in mast cell activation and its contribution to inflammatory conditions like chronic obstructive pulmonary disease (COPD) and colitis.
Main Methods:
- Generation of a novel Prss31-null mouse line using Cre/loxP homologous recombination.
- Assessment of mast cell number, degranulation patterns, and protease expression in Prss31-null mice.
- Evaluation of Prss31-null mice in cigarette smoke-induced COPD and dextran sodium sulfate-induced colitis models.
Main Results:
- Prss31-null mice showed no developmental abnormalities or compensatory increases in other protease expression.
- Activated Prss31-null mast cells degranulated similarly to wild-type mast cells.
- Prss31-null mice exhibited increased baseline airway reactivity but reduced severity in experimental COPD and colitis models.
- Specifically, Prss31-null mice had less pulmonary inflammation and fibrosis in COPD models and reduced colonic inflammation in colitis models compared to wild-type mice.
Conclusions:
- Prss31 plays a complex role, contributing to airway hyperreactivity while suppressing inflammatory responses in the lung and gut.
- Inhibiting membrane-bound Prss31 may offer therapeutic potential for mast cell-dependent inflammatory diseases such as COPD and colitis.
Related Concept Videos
Asthma I: Introduction
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.

